Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GenMark Diagnostics Inc (NASDAQ:GNMK)

11.69
Delayed Data
As of Sep 28
 -0.26 / -2.18%
Today’s Change
4.20
Today|||52-Week Range
12.17
+50.64%
Year-to-Date
GenMark Diagnostics Hits 52-Week High on Solid Prospects
Sep 28 / Zacks.com - Paid Partner Content
Why GenMark Diagnostics, Inc. Is Soaring Today
Sep 16 / MotleyFool.com - Paid Partner Content
Can the Rally in GenMark Diagnostics (GNMK) Shares Continue?
Sep 21 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close11.95
Today’s open11.94
Day’s range11.59 - 12.17
Volume191,535
Average volume (3 months)307,872
Market cap$513.8M
Dividend yield--
Data as of 09/28/2016

Growth & Valuation

Earnings growth (last year)-7.53%
Earnings growth (this year)-17.86%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+28.82%
P/E ratioNM
Price/Sales8.30
Price/Book10.46

Competitors

 Today’s
change
Today’s
% change
BEATBioTelemetry Inc-0.04-0.21%
ATRCAtriCure Inc-0.23-1.43%
XENTIntersect ENT Inc-0.11-0.68%
OSUROraSure Technologies...-0.04-0.49%
Data as of 09/28/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$39.4M
Annual profit (last year)-$42.2M
Net profit margin-107.07%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Hany Massarany
Chief Financial Officer
Scott Mendel
Corporate headquarters
Carlsbad, California

Forecasts

Search for Jobs